Unresectable Squamous Cell Carcinoma of Donor Origin Treated with Immunosuppression Withdrawal and Liver Retransplantation

American Journal of Transplantation

Volumn 4, Issue 2, 2004, Pages 278-282

  Florman, Sander ^a   Bowne, Wilbur ^a   Kim Schluger, Leona ^a   Sung, Max W ^b   Huang, Ruoqing ^c   Fotino, Marilena ^d   Thung, Swan ^c   Schwartz, Myron ^a   Miller, Charles ^a  

^a Recanati/Miller Transplantation Institute   (United States)

^b Department of Medicine ^*  (United States)

^c L/H M S H P Dept Pathol   (United States)

^d ROGOSIN INSTITUTE   (United States)

Author keywords

Donor; Immunosuppression; Liver transplantation; Malignancy, squamous cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; IMMUNOSUPPRESSIVE AGENT; MITOMYCIN;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CHEMOEMBOLIZATION; FEMALE; HISTOCOMPATIBILITY; HLA TYPING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INOPERABLE CANCER; LIVER TRANSPLANTATION; ORGAN DONOR; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REOPERATION; SQUAMOUS CELL CARCINOMA; TREATMENT WITHDRAWAL;

ADULT; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MIDDLE AGED; REOPERATION; TISSUE DONORS;

EID: 1342283091     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1600-6143.2003.00322.x     Document Type: Article

References (35)

1. Penn I. Transmission of cancer from organ donors. Ann Transplant 1997; 23: 7-12.
2. Blohme I, Brygner H. Malignant disease in renal transplant patients. Transplantation 1985; 39: 23-25.
3. Penn I. Why do immunosuporessed patients develop cancer? Crit Rev Oncol Hematol 1989; 1: 27-52.
4. Kelly DM, Emre S, Guy SR, Miller CM, Schwartz ME, Sheiner PA. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors. Cancer 1998; 83: 1237-1243.
5. Loh E, Couch FJ, Hendricksen C et al. Development of donor-derived prostate cancer in a recipient following orthotopic heart transplantation. JAMA 1997; 277: 133-137.
6. Roza AM, Johnson C, Juckett M, Eckels D, Adams M. Adenocarcinoma arising in a transplanted pancreas. Transplantation 2001; 72: 1156-1157.
7. Bodvarsson S, Burlingham W, Kusaka S et al. Donor-derived small cell lung carcinoma in a kidney transplant recipient. Cancer 2001; 92: 2429-2434.
8. Elder GJ, Hersey P, Branley P. Remission of transplanted melanoma - clinical course and tumour cell characterisation. Clin Transplant 1997; 11: 565-568.
9. Buell JF, Trofe J, Hanaway MJ et al. Transmission of donor cancer into cardiothoracic transplant recipients. Surgery 2001; 130: 660668.
10. Ruiz JC, Cotorruelo JG, Tudela V et al. Transmission of glioblastoma multiforme to two kidney recipients from the same donor in the absence of a ventricular shunt. Transplantation 1993; 55: 682-683.
11. Stephens JK, Everson GT, Elliot CL et al. Fatal transfer of malignant melanoma from multiorgan donor to four allograft recipients. Transplantation 2000; 70: 232-236.
12. Detry O, Detroz B, D'Silva M et al. Misdiagnosed malignancy in transplanted organs. Transpl Int 1993; 6: 50-54.
13. Baehner R, Magrane G, Balassanian R et al. Donor origin of neuroendocrine carcinoma in 2 transplant patients determined by molecular cytogenetics. Human Pathol 2000; 31: 1425-1429.
14. Baquero A, Foote J, Kottle S et al. Inadvertent transplantation of choriocarcinoma into four recipients. Transplant Proc 1988; 20: 98-100.
15. Jonas S, Bechstein WO, Lemmens H, Neuhaus R, Thalmann U, Neuhaus P. Liver graft-transmitted glioblastoma multiforme. A case report and experience with 13 multiorgan donors suffering from primary cerebral neoplasia. Transpl Int 1996; 9: 426-429.
16. Timmons CF, Dawson DB, Richards CS, Andrews WS, Katz JA. Epstein-Barr virus-associated leiomyosarcomas in liver transplantation recipients. Cancer 1995; 76: 1481-1489.
17. Colina F, Lopez-Rios F, Lumbreras C, Martinez-Laso J, Garcia IG, Moreno-Gonzalez. Kaposi's sarcoma developing in a liver graft. Transplantation 1996; 61: 1779-1781.
18. Kakar S, Burgart LJ, Charlton MR, Saito Y, Halling K, Thibodeau SN. Origin of adenocarcinoma in a transplanted liver determined by microsatellite analysis. Hum Pathol 2002; 33: 435-436.
19. Rosai J. Special techniques in surgical pathology. In: Rosai J (ed): Ackerman's Surgical Pathology, 8th edn. St. Louis, MO: MosbyYear Book, Inc., 1996: 29-62.
20. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225-235.
21. Fucich LF, Cheles MK, Thung SN, Gerber MA, Marrogi AJ. Primary versus metastatic hepatic carcinoma. An immunohistochemical study of 34 cases. Arch Pathol Lab Med 1994; 116: 927-930.
22. Jain AB, Yee LD, Nalesnik MA et al. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 1998; 66: 1193-1200.
23. Haagsma EB, Hagens VE, Schaapveld M et al. Increased cancer risk after liver transplantation: a population-based study. J Hepatol 2001; 34: 161-164.
24. Marsh JW, Jr Esquivel CO, Makowka L et al. Accidental transplantation of malignant tumor from a donor to multiple recipients. Transplantation 1987; 44: 449-450.
25. Detroz B, Detry O, D'Silva M et al. Organ transplantation with undetected donor neoplasm. Transplant Proc 1991; 23: 2657.
26. Donovan JA, Simmons FA, Esrason KT et al. Donor origin of a post transplant liver allograft malignancy identified by fluorescence in situ hybridization for the Y chromosome and DNA genotyping. Transplantation 1997; 63: 80-84.
27. Morse JH, Turcotte JG, Merion RM, Campbell DA, Burtch GD, Lucey MR. Development of a malignant tumor in a liver graft transplant procured from a donor with a cerebral neoplasm. Transplantation 1990; 50: 875-877.
28. Frank S, Muller J, Bonk C, Haroske G, Schackert HK, Schackert G. Transplantation of glioblastoma multiforme through liver transplantation [letter]. Lancet 1998; 352: 31.
29. Wilson RE, Hager EB, Hampers CL, Corson JM, Merrill JP, Murray JE. Immunologic rejection of human cancer transplanted with a renal allograft. NEJM 1968; 278: 479-483.
30. Kaufman HM, McBride MA, Cherikh WS, Spain PC, Marks WH, Roza AM. Transplant tumor registry: Donor related malignancies. Transplantation 2002; 74: 358-362.
31. Roediger WE, Dymock RB. Primary squamous carcinoma of the liver: clinical and histopathological features. Aust N Z J Surg 1991; 61:720-722.
32. Ayoub J-P, Abbruzese MC, Lenzi R, Raber MN, Abbruzzese JL. Unknown primary tumors metastatic to liver. J Clin Oncol 1998; 16: 2105-2112.
33. Barkholt L, Billing H, Juliusson G, Porwit A, Ericzon BG, Groth CG. B-cell lymphoma in transplanted liver. Clinical, histological and radiological manifestations. Transpl Int 1991; 4: 8-11.
34. Penn I. Transmission of cancer with donor organs. Transplant Proc 1988; 20: 739-740.
35. Penn I. Malignancies associated with renal transplantation. Urology 1977; 10: S57-S63.